- Diagnostic Différentiel
Drug Information for DRISDOL ERGOCALCIFEROL, USP 50,000 IU Capsule (sanofi-aventis U.S. LLC): INDICATIONS AND USAGE
- CLINICAL PHARMACOLOGY
- INDICATIONS AND USAGE
- ADVERSE REACTIONS
- DOSAGE AND ADMINISTRATION
- HOW SUPPLIED
- PRINCIPAL DISPLAY PANEL - 1.25 mg capsule
- Liens externes liés à DRISDOL ERGOCALCIFEROL, USP 50,000 IU Capsule (sanofi-aventis U.S. LLC)
DRISDOL is indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin D resistant rickets, and familial hypophosphatemia.
- Drug Information Provided by National Library of Medicine (NLM).